Jennifer Seal

Jennifer Seal currently serves as the Sr. Director of Pharmacokinetics, Drug Disposition, and Clinical Pharmacology at Glaukos Corporation, a position held since July 2023. Prior to this role, Jennifer was the Global Director of Immunology, Immunosafety, and Clinical Pharmacology at AbbVie from May 2020 to June 2023, where responsibilities included leading a team of clinical pharmacologists and overseeing strategic initiatives in non-clinical pharmacokinetics and immunogenicity assessments. Jennifer's career began at Allergan, progressing through various positions in clinical pharmacology from Associate Director to Senior Scientist. Jennifer also gained research experience as a Postdoctoral Fellow at the Massachusetts Institute of Technology, focusing on the characterization of covalent adducts and nitrated proteins. Jennifer holds a PhD in Chemistry from Vanderbilt University and a B.S. in Chemistry from Bradley University.